about
Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantationHuman nutrition, the gut microbiome and the immune systemThe PD-1 pathway in tolerance and autoimmunityImmunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantationStaphylococcal Superantigens Spark Host-Mediated Danger SignalsRegulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in TransplantationDeletional and regulatory mechanisms coalesce to drive transplantation tolerance through mixed chimerismThe expanding role of immunopharmacology: IUPHAR Review 16Induced regulatory T cells: mechanisms of conversion and suppressive potentialPI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicityThe staphylococcal enterotoxin (SE) family: SEB and siblingsCancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advancesImmunosuppressive and anti-inflammatory properties of engineered nanomaterialsBeneficial role of rapamycin in experimental autoimmune myositisTNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagyStimulation of Wnt/ß-catenin pathway in human CD8+ T lymphocytes from blood and lung tumors leads to a shared young/memory phenotypeProfiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational studyEstablishment of lal-/- myeloid lineage cell line that resembles myeloid-derived suppressive cellsNanoparticles Effectively Target Rapamycin Delivery to Sites of Experimental Aortic Aneurysm in RatsParadoxical effects of rapamycin on experimental house dust mite-induced asthmaLow dose rapamycin exacerbates autoimmune experimental uveitisPI3K and cancer: lessons, challenges and opportunitiesDifferential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B CellsConstitutive reductions in mTOR alter cell size, immune cell development, and antibody production.Multi-scale optical imaging of the delayed type hypersensitivity reaction attenuated by rapamycinRapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac functionSirolimus in pediatric renal transplantation.Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorActivating Autophagy by Aerobic Exercise in Mice.Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.Pathogenic mechanisms in systemic lupus erythematosus.Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.Downregulation of MicroRNA-193b-3p Promotes Autophagy and Cell Survival by Targeting TSC1/mTOR Signaling in NSC-34 Cells.MS4a4B, a CD20 homologue in T cells, inhibits T cell propagation by modulation of cell cycle.mTORC1-S6K activation by endotoxin contributes to cytokine up-regulation and early lethality in animals.Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioningRegulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway.Tolerogenic dendritic cells: all present and correct?Small molecules as friends and foes of the immune system.
P2860
Q21284774-3178EB4A-889E-4DC9-8AFD-E57CC0A758AEQ24620449-CAFFBEBE-C997-4A99-AB69-95815D0CB82CQ24633549-C1A1974A-6A55-42F9-A660-5DB2B8110935Q26751433-3C63446A-F524-4310-BF74-6A97944A971EQ26766421-CCBE0123-7A9E-4207-B9E5-6F9709E2EC33Q26784460-CF073D72-B6D5-4CC0-A7DB-589E1D2E90DFQ26801029-BB096414-80C0-446F-8E33-872BF5EFA047Q26801862-BEBA044D-5FB1-483F-9FC0-3077081937F0Q26823869-16586B19-5E64-4A25-9229-FD710F371AECQ26825729-6C35148D-B8CF-46D1-A2C8-AD15BABF79C6Q26830220-50CE5A92-F684-436D-8C8B-ED08BF867358Q26863779-E5CD99B7-3818-4A32-912C-C92D77B9DF99Q27005267-4A2A6E03-1061-470C-B48A-731A5320061CQ27306863-9CC4D7D6-02E5-43A5-9AFD-95D8A8BCF0A1Q27311305-9AB65C7F-0BDE-4501-A460-63CDF240D492Q28481655-F87C1012-AAE6-43CE-BB02-35451EDB88D0Q28484885-9455DEC8-7273-4391-BA06-A8EADF85E613Q28545000-66A15812-E04B-4AC6-A38C-C3D9D79A89BEQ28552112-5849D49B-DD3F-466D-B397-72572305FB90Q28728802-595E973C-F684-4F06-B669-AEA2105118AFQ28730115-E4532B1A-DB6B-4CDE-83BE-21A84EC76743Q30080017-B07C25C8-9653-4D6A-96ED-BD74951BBB6EQ30279164-E17AF25C-E662-4EC4-B0CD-B781A60F8DD7Q30498613-8140925D-9382-4934-ACF3-4CF0936336FCQ30567473-A7142894-24BE-439D-8B85-0A195E62FD84Q30576097-F572A191-10B1-47A8-8094-8E13403DBCEDQ33397668-7762289F-1B4A-4F22-9E76-61AA9FBF603FQ33597663-A7ECC411-DF3B-40A0-BFD2-35DF6A27AA1FQ33613673-57EA78D4-EDBD-48F6-8654-87AF789F896EQ33676236-0C08A799-4101-4897-A0A5-76737D4E6F06Q33715441-3DCD2D48-9A1D-46D4-86E4-8B72C918892BQ33715480-8FE057CD-582B-4BA8-B8C7-52C3AD23D30BQ33736536-47C8D23F-213C-47F9-947D-26EC61DBCE5BQ33745039-7F805892-3766-4B65-8E8D-218A24256537Q33784215-7A2A1DD1-4B5B-47FA-8DC4-382FBB9A1ECCQ33796796-6A56A883-01A4-4030-951C-80A0C3443181Q33804736-0141E46D-05A5-46A6-82A2-57EEE9F28BCCQ33805859-167B335B-6EFC-423B-9A53-A25CD9C4DA19Q33811958-7DBDF1A0-22A7-4C4B-9566-7A9005E571E8Q33852354-644233A0-4438-4356-BD33-39170B27117C
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Immunoregulatory functions of mTOR inhibition.
@ast
Immunoregulatory functions of mTOR inhibition.
@en
type
label
Immunoregulatory functions of mTOR inhibition.
@ast
Immunoregulatory functions of mTOR inhibition.
@en
prefLabel
Immunoregulatory functions of mTOR inhibition.
@ast
Immunoregulatory functions of mTOR inhibition.
@en
P2860
P356
P1476
Immunoregulatory functions of mTOR inhibition
@en
P2093
Angus W Thomson
Giorgio Raimondi
P2860
P304
P356
10.1038/NRI2546
P577
2009-05-01T00:00:00Z